Monday, June 20, 2011

FDA Panel Votes Yes for Regeneron's Eylea - June 20, 2011

Having trouble viewing this email? View in Browser.
ClinicaSpace Focus
   Monday, June 20, 2011 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS

TOP SPONSOR

Advancing Oncology. Changing Medicine. Crown Bioscience Inc. is a US-based oncology service company committed to advancing anti-cancer therapeutics through the preclinical and drug development stages. Our multi-disciplinary team of experts, located in two research campuses in Beijing and Shanghai, provides an integrated service solution from your idea to an enabling IND, including: preclinical, translational and clinical capabilities. Crown Bio offers a full range of predictive models; such as HuPrime™ xenografts , OmniPanel™ cell based screens, and SnapShot™ translational research services to provide data to help you select the development candidate with the highest chance of success.

To learn more about our unique portfolio and breadth of services, visit www.crownbio.com or call us at 603-686-9330.
HeadHtml
•  FDA Panel Unanimously Backs Approval Of Regeneron Pharmaceuticals, Inc. (REGN) Eye Drug More...
•  Clinical Development Plan for Pediatric Use of PROLOR Biotech (PBTH)'s Long-Acting Human Growth Hormone has Been Accepted for Review by European Medicines Agency More...

More BLA/NDA/ANDA News
More IND News
More MAA News
HeadHtml
•  Johnson & Johnson (JNJ) Recalling 40K Bottles of Risperdal Due to Bad Odor More...

More Discontinuations News
More Recalls and Warning News
HeadHtml
•  Pfizer Inc. (PFE), Acura Pharmaceuticals, Inc. Abuse-Resistant Painkiller Gets FDA Nod; Acura Stock Rises 26.61% @12:58PM EDT More...
•  Abbott Laboratories (ABT) Receives FDA Approval for a New Six-Month Formulation of Lupron Depot(R) (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer More...

More Drug Approval News
HeadHtml
•  Roche (RHHBY) Drug Positive in Mid-Stage Skin Cancer Trial More...
•  Curis, Inc. (CRIS) Announces Presentation of Positive Vismodegib Pivotal Clinical Data in Advanced Basal Cell Carcinoma More...
•  Chelsea Therapeutics, Inc. (CHTP) Announces Successful Completion of Northera QTc Study More...
•  Cellceutix's Kevetrin(TM) Slows Pancreatic Cancer Tumor Growth by 94%; Protocol Towards Clinical Trials Nearing End More...
•  Topica Pharmaceuticals Announces Positive Results From Phase 1/2a Trial of Luliconazole for Treatment of Onychomycosis More...

More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
HeadHtml
•  New 'Shotgun' Vaccine Seeks and Destroys Cancer Cells, University of Leeds and Mayo Clinic Study More...
•  Scientists Find Candidate for New TB Vaccine, Study in Proceedings of the National Academy of Sciences More...
•  Medtronic, Inc. (MDT)'s Thoracic Stent Graft System Study Reveals Promising Results More...
•  Merck & Co., Inc. (MRK)'s Gardasil Cuts Rate of Cervical Abnormalities More...
•  Experimental Radioprotective Drug Safe for Lung Cancer Patients, Says University of Pittsburgh Cancer Institute (UPCI) Study More...

More General Clinical Research News
Events

BioSurplus Announces TWO GIANT AUCTIONS

BioSurplus will be hosting two large public auctions, one for Roche in Palo Alto / San Francisco Bay and the second a campus-wide auction of a global biotech located in San Diego. Details of the auctions can be found atauctions.biosurplus.com

Roche Palo Alto / San Francisco Bay Area Auction Details
Over 1200 items are available in this auction. Viewing will be held on June 2, 3 and 7, 2011 from 9 am to 5 pm each day. The items are located at 3431 Hillview Ave., Bldg R3, Palo Alto, CA 94304

Global Biotech - San Diego Campus Liquidation
The San Diego campus liquidation will have over 1500 pristine laboratory equipment items. Auction viewing dates are June 13-17, 2011 from 10 am to 6 pm by appointment only. Please call 858-550-0800 x222. An open viewing will be held on June 22, 2011 from 10 am to 6 pm. Items are being added to the online auction site daily.

Please click here for more information.
Latest Market Insight

Advances in Drug-Diagnostic Co-Development

• Understand the current regulatory environment for both diagnostics and drugs within the EU and the US and how these relate to their co-development.
• Understand the biomarker discovery and validation process.
• Using case studies discover how drugs and their companion diagnostics have already received approval in the US and EU.

Click Here for More Information
Tower: Facebook

Top Jobs
Pharm Country (Ridgefield, Connecticut)

Boehringer Ingelheim Pharmaceuticals, Inc.
Director, Clinical Research (MD) - Diabetes
You will ensure that goals and objectives for a drug development program are met. Provides medical/scientific and technical direction to the planning, implementation, conduct, completion, etc.

Biotech Beach (Irvine, California)

Allergan Inc.
Clinical Study Specialist
Develops, evaluates, and executes all essential clinical trial documents and clinical trial agreements (CTAs). Aligns execution activities with agreed upon project priorities, timings and quality specifications. Etc.

BioMidwest (Indianapolis, Indiana)

Eli Lilly and Company
Principal Research Scientist, Immunologist - Autoimmune Disease
Serve as a source of state-of-the-art scientific knowledge in the field of immuno-inflammation especially as this applies to autoimmune disease; exert influence on research direction and the choice of experimental approaches taken. Etc.

Biotech Bay (South San Francisco, California)

Bayside Solutions, Inc.
Pre-Clinical Research Associate, In Vivo Pharmacology
We are currently seeking an experienced and motivated Research Associate with experience in Pre-Clinical in vivo pharmacology. Experiments will assess both the pharmacodynamic and pharmacokinetic nature of novel variants, utilizing various animal models of disease.

BioCapital (College Park, Maryland)

Takeda Pharmaceuticals
Manager/Sr. Manager, Clinical Science & Outcomes
Addresses unsolicited requests for scientific and pharmacoeconomic data concerning Takeda Pharmaceuticals products to health care professionals and relevant thought leaders of, but not limited to, regionally based managed care organizations, pharmacy benefit management companies, etc.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!


BIO Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Washington, DC area.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

BIO Career Fair, Washington DC, June 27, 2011
Biotech Beach Career Fair, San Diego, CA September 22, 2011

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
HeadHtml
•  Aoxing Pharmaceutical Company Inc. (AXN) Announces Issuance of Chinese Patent for Midazolam Maleate Oral Film More...
•  Suven Life Sciences Ltd Secures 2 Product Patents for their NCEs in the Key Markets in the World More...

More Patent News
Feature

Hot Company

Tolerx, Inc.
300 Technology Square, 3rd Floor
Cambridge, Massachusetts 02139 U.S.A.
Phone: 269-668-3336 Fax: 269-668-4151

Tolerx, Inc. is a biopharmaceutical company engaged in discovering and developing new therapies designed to treat patients with immune related diseases.
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the ClinicaSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Suvarna Sheth, Matt Thwin, Maysa Darwish

ClinicaSpace.com - Clinical Trials. Clinical Research. Community.
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2011 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply join the ClinicaSpace Focus here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.
 


No comments: